July 14, 2025 3-5pm ET
Monday on The Robert Scott Bell Show:
Special Guest Doug Green
At The Freedom People, we believe true freedom isn’t just a dream—it’s a lifestyle you can create. We empower professionals, entrepreneurs, and influencers to break free from societal limitations and reclaim control over their lives, careers, and businesses.
Our flagship program, the 5 Pillars of Freedom Transformation, is designed to guide you on a journey of personal and professional empowerment. Through five foundational areas—health, spirituality, law, education, and wealth—we equip you with the tools to transcend traditional constraints and unlock your full potential.
In addition to this life-changing program, we specialize in:
✔ Private Membership Associations (PMAs): Secure your business and operate confidently outside of unnecessary regulatory interference.
✔ Trust Creation: Protect your wealth and legacy with customized solutions.
✔ Freedom-Focused Strategies: From holistic marketing to education, we help you build a life that aligns with your values.
Since our founding, we’ve helped countless individuals and organizations find independence, success, and fulfillment.
💡 Looking to take control of your future? Whether you’re seeking personal sovereignty or professional autonomy, we provide the resources, guidance, and community to help you thrive.
📩 Let’s connect and start your journey to true freedom!
🔗 https://thefreedompeople.org
House Democrats Demand Answers From CDC Over Recent Changes to Vaccine Advisory Panel House Democrats are raising alarm over the abrupt restructuring of the CDC’s Advisory Committee on Immunization Practices (ACIP) by Health and Human Services Secretary Robert F. Kennedy Jr. In a formal request to the CDC’s Chief of Staff, lawmakers demanded an urgent briefing and documentation regarding the removal of all 17 previous ACIP members and the appointment of seven new individuals, some of whom are affiliated with vaccine-skeptical positions. The new committee has already refused to endorse certain flu vaccines containing thimerosal and has initiated a review of the entire childhood immunization schedule, including reevaluating the necessity of the hepatitis B vaccine at birth. One controversial moment cited was the inclusion of testimony from Lyn Redwood, former president of Children’s Health Defense, a group known for questioning vaccine safety. Lawmakers expressed concern that Kennedy’s restructuring threatens the integrity of vaccine policy by introducing ideological bias into what has historically been a science-driven process. The removal of established scientific consensus documents, such as the CDC’s statement dismissing a link between thimerosal and autism, has further intensified Democratic concerns. They warn that such politically influenced changes could undermine public trust in immunization programs, potentially reversing decades of public health progress. House Democrats have set a deadline of July 24 for the CDC to provide information on the selection process and communications related to the new appointments.
EPA Releases ‘Everything We Know’ on Contrails and Geoengineering The Environmental Protection Agency (EPA) has published a comprehensive report compiling the current scientific understanding of aviation contrails and geoengineering techniques, including solar radiation management, reflecting growing public and policy interest in weather modification. Contrails—water vapor trails produced by jet engines—have garnered attention for their impact on climate through radiative forcing and potential contribution to global warming. The EPA’s document reviews peer‑reviewed studies on contrail formation, persistence, and how they trap infrared radiation, as well as their broader climate implications. In parallel, the report addresses geoengineering proposals such as aerosol injection into the stratosphere and marine cloud brightening, outlining both their theoretical mechanisms and critical knowledge gaps. While geoengineering is not endorsed as a policy, the report emphasizes the need for further research due to concerns about ecological side effects, unpredictable atmospheric impacts, and governance challenges. Experts quoted in the report stress that while contrails represent a tangible climate factor, geoengineering remains speculative and potentially risky. The publication marks a milestone in regulatory transparency, offering journalists, scientists, and the public access to foundational data and analysis on contrails and geoengineering. The report is expected to inform future discussions around aviation emissions regulation and international climate policy, ensuring that any consideration of geoengineering strategies is grounded in science and subject to rigorous oversight.
Scoop: RFK Jr. postpones Obamacare coverage panel meeting HHS Secretary Robert F. Kennedy Jr. has abruptly postponed the scheduled July meeting of the U.S. Preventive Services Task Force (USPSTF), the independent panel responsible for recommending preventive health measures that insurance plans must cover under the Affordable Care Act. The cancellation, announced just days before the session originally set to address cardiovascular prevention strategies—such as promoting healthy diets, physical activity, and weight management—has sparked alarm among healthcare experts who fear potential politicization of the task force. The move follows a recent Supreme Court decision in Kennedy v. Braidwood affirming the HHS Secretary’s authority to appoint and dismiss USPSTF members, a shift that has raised concerns about ideological influence on the traditionally science-driven body. Conservative groups have reportedly urged Kennedy to replace current task force members with individuals more aligned with his agenda. Meanwhile, public health advocates emphasize the critical role of the USPSTF’s evidence-based recommendations—used to determine coverage for cancer screenings, immunizations, and other lifesaving services—and warn that sidelining the panel could undermine public trust and disrupt access to essential preventive care. A coalition of more than 100 medical organizations, including the AMA and ACP, has called on Congress to safeguard the task force’s independence and transparency. HHS has stated it looks forward to continued engagement with the task force, but no rescheduling timeline has been provided.
Hour 2
Special Guest: Edward Szall
Host: The Agenda on 𝕏 | Producer @DiedSuddenly_
Bondi says all charges against doctor who allegedly destroyed COVID vaccines have been dropped U.S. Attorney General Pam Bondi has directed the Department of Justice to dismiss all federal charges against Dr. Kirk Moore, a Utah plastic surgeon previously accused of destroying approximately $28,000 worth of government‑supplied COVID‑19 vaccines, issuing fraudulent vaccination cards, and administering saline shots in lieu of actual vaccines at parents’ requests. Bondi emphasized that Moore “gave his patients a choice when the federal government refused to do so” and did not deserve the severe prison sentence he was facing. His lawyer and co‑defendants, including clinic staff, argued that Moore acted to honor informed consent without receiving any personal financial gain and that no viable vaccines were destroyed. Mid‑trial jury proceedings were paused when Bondi intervened. Dr. Moore, reportedly “completely stunned” by the dismissal, stated that he acted based on patient autonomy and medical ethics. The case had become a focal point in debates over vaccine mandates and medical freedom, with supporters, including Representative Marjorie Taylor Greene and HHS Secretary RFK Jr., praising Moore as a principled provider. Bondi credited Greene’s advocacy for bringing the matter to her attention and affirmed that justice was served by ending what supporters termed a “weaponized” prosecution under a politically motivated agenda.
These States Now Allow OTC Ivermectin, and More May Follow As of July 2025, four states—Tennessee, Arkansas, Idaho, and Louisiana—have enacted laws permitting over-the-counter (OTC) sales of ivermectin, a drug traditionally used for parasitic infections but widely promoted (without scientific support) early in the COVID-19 pandemic. Tennessee led the movement in 2022, with Arkansas and Idaho following in spring 2025, and Louisiana implementing regulations that require pharmacist counseling, a pharmacist-administered risk assessment, and standing orders from licensed prescribers. Unlike these more structured approaches, Tennessee, Arkansas, and Idaho have fewer safeguards. Pharmacists in these states now play a critical role in patient education, navigating safety concerns—especially regarding contraindications for pregnant or breastfeeding individuals, children, and the elderly—and addressing misconceptions about ivermectin’s use for COVID-19. The shift has drawn concern from health experts citing studies showing ivermectin’s inefficacy against COVID-19. Clinical trials like ACTIV‑6 failed to demonstrate any reduction in recovery time or hospitalizations with ivermectin. Moreover, authoritative reviews in NEJM and JAMA debunked earlier claims, culminating in a major meta‑analysis retraction tied to fraudulent data. As red states continue introducing similar bills in Texas, New Hampshire, North Carolina, Pennsylvania, Georgia, Alabama, West Virginia, Missouri, and South Carolina, pharmacy professionals are being urged to balance compassion with evidence-based guidance and patient safety amidst growing medical freedom pressures.
Antidepressant Withdrawal Is a Major Public Health Issue, Experts Warn A comprehensive review reveals that long-term antidepressant use significantly increases the risk of severe, prolonged withdrawal symptoms—a problem grossly underestimated by short-term drug industry studies. Analysis of NHS patient data indicates that those on antidepressants for over two years are ten times more likely to experience withdrawal, five times more likely to suffer severe symptoms, and 18 times more likely to endure ongoing effects compared to users taking them for six months or less. While short-duration users generally face mild, temporary discomfort, individuals on long-term regimens report debilitating issues—ranging from emotional distress, cognitive impairment, and neurological symptoms to physical ailments—that can persist for months or even years and often force them back onto medication. This disparity results from earlier research relying heavily on trials lasting just 8–12 weeks, which failed to capture real-world experiences. Critics point out that pharmaceutical-funded studies framed withdrawal as brief and mild, but these findings ignore the broader context of extended usage. The article urges healthcare providers to acknowledge the prevalence and seriousness of withdrawal, promote gradual tapering protocols, and conduct further research into long-term effects. With millions of Americans on antidepressants for years, the authors call this a silent public health crisis demanding urgent clinical attention, guideline updates, and transparent patient education.
Chemotherapy may help cancer spread, new study shows A recent mouse-based study reveals that the widely used chemotherapy drug cyclophosphamide may inadvertently promote cancer metastasis, raising serious questions about treatment protocols. Researchers found that pretreating healthy mice with cyclophosphamide led to significantly increased cancer cell adhesion in the lungs shortly after tumor cells were introduced. The drug appeared to weaken tight junctions between vascular endothelial cells, resulting in “leaky” blood vessels, and altered the structure of the basement membrane—a dense matrix beneath the endothelium—making it more conducive to cancer cell attachment and survival. These two changes created an environment that encouraged the dissemination of cancer rather than its suppression. The study also noted a surge in matrix metalloproteinase-2 (MMP-2), an enzyme known to degrade structural proteins in the extracellular matrix and facilitate tumor spread. These results align with previous research suggesting chemotherapy can unintentionally create conditions favorable to metastasis by increasing structures like TMEM (Tumor Microenvironment of Metastasis), which assist cancer cells in entering the bloodstream. While chemotherapy remains effective in reducing primary tumor size, the findings underscore the need for adjunct therapies to counteract these metastatic risks and warrant further investigation into treatment sequencing and long-term effects on the tumor microenvironment.
Remember Friends, The Power to Heal is Yours!
